Back

Samik Pharmaceutical shares surge 16.18% on long-acting thymosin alpha 1 patent

Verifying
  • Samik Pharmaceutical registered a domestic patent for long-acting thymosin alpha 1 microspheres.
  • 16.18%: Shares reached 9,190 won on KOSDAQ at 3:23 p.m. on the 14th.
  • Samik Pharmaceutical completed the patent registration on Aug. 27.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.